Britannia Bud Company is a UK-focused company providing services and consulting in the areas of cosmetics, food and nutraceutical products. They stand to significantly profit in the immediate term from the regulation and rationalization of the CBD market in the UK and Europe and believe they will be a global leader in CBD formulations related to skin care.
They are also developing a global supply chain to provide European companies with ingredients, formulations and testing to develop cosmetics, food and nutraceutical products containing CBD.
They are acquiring a controlling stake of a business that generated £1.6mm of pre-tax earnings last year, and believe they can double earnings in the year ahead.
Read more about Britannia Bud Company
Peter Shippen | CEO@Britannia Bud Company
Peter is a British-born entrepreneur, best known for his work in the Canadian financial services industry, where he founded a business that he grew and ultimately sold to Purpose Investments.
Peter spent 7 years working in Canadian banking, in investment research, holding increasingly senior positions at Bank of Montreal and TD Bank. In 2007, Peter acquired a company that would eventually become Redwood Asset Management. Under his tenure, AUM grew steadily despite market challenges, and was acquired by Purpose Investments in 2016. As an early investor in the Canadian cannabis market, Peter was involved in the conception the Medical Cannabis and Wellness ETF that is listed on the LSE under CBDX.
Peter is a CFA Charterholder, CAIA Charterholder and recently received his ICD designation through the Institute for Corporate Directors and the University of Toronto. Peter completed his undergraduate degree in economics at Wilfrid Laurier University.